Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 0.5387
11 %
$ 559 M
Market Cap
-0.51
P/E
1. INTRINSIC VALUE
Balance Sheet
Tilray Brands, Inc.
| Current Assets | 678 M |
| Cash & Short-Term Investments | 261 M |
| Receivables | 102 M |
| Other Current Assets | 315 M |
| Non-Current Assets | 3.66 B |
| Long-Term Investments | 7.86 M |
| PP&E | 574 M |
| Other Non-Current Assets | 3.08 B |
| Current Liabilities | 299 M |
| Accounts Payable | 105 M |
| Short-Term Debt | 39 M |
| Other Current Liabilities | 155 M |
| Non-Current Liabilities | 593 M |
| Long-Term Debt | 348 M |
| Other Non-Current Liabilities | 245 M |
EFFICIENCY
Earnings Waterfall
Tilray Brands, Inc.
| Revenue | 789 M |
| Cost Of Revenue | 566 M |
| Gross Profit | 223 M |
| Operating Expenses | 398 M |
| Operating Income | -175 M |
| Other Expenses | 47.7 M |
| Net Income | -222 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Tilray Brands, Inc.
| Net Income | -222 M |
| Depreciation & Amortization | 127 M |
| Capital Expenditures | -29.2 M |
| Stock-Based Compensation | 0 |
| Change in Working Capital | -8.87 M |
| Others | 103 M |
| Free Cash Flow | -60.2 M |
Wall Street Analysts Price Targets
Tilray Brands, Inc.
Wall Street analysts predict an average 1-year price target for TLRY of $2.59 , with forecasts ranging from
a
low of
$2 to a high of $4.15 .
TLRY Lowest Price Target
Wall Street Target
2 USD
271.26%
TLRY Average Price Target
Wall Street Target
2.59 USD
381.32%
TLRY Highest Price Target
Wall Street Target
4.15 USD
670.37%
4. DIVIDEND
ANALYSIS
TLRY does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Tilray Brands, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
35.4 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Americans Should Buy Canadian Cannabis Companies
Canadian LPs offer compelling risk/reward versus U.S. cannabis stocks, with stronger balance sheets, tangible book value, and global opportunities due to federal legality. Despite recent rallies, Canadian LPs remain cheap on enterprise value to EBITDA, especially Village Farms, Organigram, and Tilray Brands, which I hold in my model portfolio. U.S. MSOs face significant risks from 280E tax liabilities and negative tangible equity, making Canadian LPs a safer bet for cannabis investors right now.
seekingalpha.com
- 4 days ago
Here's why the Tilray Brands stock price has imploded
Tilray Brands stock price surged by over 15% in a high-volume environment on Wednesday. It soared to $0.4852, with its daily volume jumping to over $40 million, much higher than the three-month average of $26 million.
invezz.com
- 6 days ago
Breckenridge Distillery Unveils Limited-Edition Collectors Art Series Collaboration with Renowned Artist Miles Toland
For Its Fifth Annual Collectors Art Series, Breckenridge Distillery Partners with Visionary Artist to Create Label for Its New Calvados Cask Release For Its Fifth Annual Collectors Art Series, Breckenridge Distillery Partners with Visionary Artist to Create Label for Its New Calvados Cask Release
globenewswire.com
- 1 week ago
Tilray Brands, Inc. (TLRY) Stock Declines While Market Improves: Some Information for Investors
Tilray Brands, Inc. (TLRY) reached $0.4 at the closing of the latest trading day, reflecting a -2.84% change compared to its last close.
zacks.com
- 1 week ago
Montauk Brewing Celebrates 13 Years of Brewing with Faherty Collaboration and Beach Clean Up with the Surfrider Foundation
Two iconic coastal-living brands team up for a limited-edition summer beer and capsule collection Two iconic coastal-living brands team up for a limited-edition summer beer and capsule collection
globenewswire.com
- 1 week ago
Here Is A List Of 3 Canadian Marijuana Stocks To Watch 2025
The outlook for investing in marijuana stocks has changed for many. The sector is facing continuous dips and a serious lack of upward momentum. This has left many wondering what to do and how to take action to recoup their investment. It seems that, if not almost all, shareholders share the same fate. Shareholders will have to either cut their losses or continue to be patient till there is a change in the market.
marijuanastocks.com
- 2 weeks ago
Tilray Medical Receives Italy's First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use
SAVONA, Italy, June 24, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a significant milestone in its European expansion with the introduction of three new medical cannabis flower varieties in Italy. Through its wholly-owned subsidiary, FL Group, Tilray has become the first company in Italy to receive official authorization from the Ministero della Salute (Italian Ministry of Health) to import and distribute proprietary Tilray Medical-branded medical cannabis flower for therapeutic use.
globenewswire.com
- 2 weeks ago
Elevate Your Summer with Canada's Leading Cannabis Brands and Products by Tilray Brands
Tilray Launches a Curated Selection of Canadian Cannabis Beverages, Vapes, and Pre-Rolls to Enrich Your Summer Activities Tilray Launches a Curated Selection of Canadian Cannabis Beverages, Vapes, and Pre-Rolls to Enrich Your Summer Activities
globenewswire.com
- 2 weeks ago
Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today
Tilray Brands, Inc. (TLRY) closed at $0.38 in the latest trading session, marking a -9.07% move from the prior day.
zacks.com
- 3 weeks ago
3 Canadian Cannabis Stocks Traders Are Watching Closely This Week
Top Canadian cannabis stocks are gaining fresh attention as U.S. markets show signs of acceleration. The U.S. cannabis industry is projected to reach $45 billion by 2025. Furthermore, analysts expect it to grow past $75 billion before 2030. This momentum is driven by rising consumer demand and favorable legislative trends. Recently, federal policymakers have signaled potential changes to cannabis scheduling.
marijuanastocks.com
- 3 weeks ago
Tilray Brands' Stockholders Approve Reverse Stock Split; Company Pauses Implementation as It Evaluates Timing and Stock Price
NEW YORK and LEAMINGTON, Ontario, June 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the vote for an amendment of the Company's Fifth Amended and Restated Certificate of Incorporation, in order to implement a reverse stock split of the Company's common stock at a ratio ranging from 1-to-10 to 1-to-20 (the “Reverse Stock Split”), passed at the special meeting of stockholders. The Company also announced a pause on the implementation of the newly-authorized reverse stock split while further exploring all options related to timing of the reverse split as it evaluates timing and stock price.
globenewswire.com
- 4 weeks ago
Here's why the Tilray Brands stock has crashed, and what's next?
Tilray Brands stock price has collapsed to its all-time low as concerns about its business continued. It has plunged by 70% this year and 76% in the last twelve months.
invezz.com
- 4 weeks ago
8. Profile
Summary
Tilray Brands, Inc. TLRY
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 559 M
Dividend Yield
0.00%
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Contact
265 Talbot Street West, Leamington, ON, N8H 5L4
https://www.tilray.com
IPO
Date
July 19, 2018
Employees
2650
Officers
Ms. Nyree Pinto
Chief Human Resources Officer
Mr. Lloyd Brathwaite
Chief Information Officer
Mr. Roger Savell
Chief Administrative Officer & Chief Financial Officer of International
Mr. Blair MacNeil CMA, CPA
President of Tilray Canada
Ms. Berrin Noorata
Chief Corporate Affairs Officer
Mr. Ty H. Gilmore
President of U.S. Beer
Mr. Irwin David Simon
President, Chief Executive Officer & Chairman
Mr. Mitchell S. Gendel J.D.
Global General Counsel & Corporate Secretary
Mr. Carl A. Merton CA, CBV, CPA
Chief Financial Officer & Principal Accounting Officer
Ms. Denise Menikheim Faltischek
Chief Strategy Officer & Head of International